Results 1 to 10 of about 3,323,629 (269)

Epidemiological profile of COVID-19 in patients with prostate cancer undergoing androgen deprivation therapy at a Brazilian Cancer Center [PDF]

open access: yesEinstein (São Paulo), 2023
Objective To describe the epidemiological aspects of COVID-19 in patients with prostate cancer who received androgen deprivation therapy and those who did not.
Isabela Granato Travalini   +6 more
doaj   +1 more source

Impact of advanced prostatic cancer treatment on quality of life and sexual function

open access: yesBrazilian Journal of Oncology, 2023
INTRODUCTION: The studying the quality of life after cancer treatment has become a priority in oncology. Objectives: To evaluate the impact of different treatments for recurrence prostate cancer on quality of life and sexual activity.
Fernando Parma Marsicano, Andy Petroianu
doaj   +1 more source

Androgen deprivation therapy and radiotherapy in intermediate-risk prostate cancer: A systematic review and meta-analysis

open access: yesFrontiers in Endocrinology, 2023
ObjectivesAndrogen deprivation therapy combined with radiotherapy for intermediate-risk prostate cancer is still a matter of debate. We conducted a meta-analysis to evaluate the necessity of androgen deprivation therapy combined with radiotherapy for ...
Jiuzhou Chen   +14 more
doaj   +1 more source

Androgen deprivation therapy and hormonal status in men with COVID-19

open access: yesВестник урологии, 2023
Severe course of COVID-19 among men compared to the female led to a detailed study of the hormonal status of men with COVID-19. The earliest works about this focused on the incidence and severity of COVID-19 depending on the intake of androgen ...
A. A. Kamalov   +4 more
doaj   +1 more source

Long-term treatment outcomes of intermittent androgen deprivation therapy for relapsed prostate cancer after radical prostatectomy. [PDF]

open access: yesPLoS ONE, 2018
PURPOSE:Intermittent androgen deprivation therapy is an effective treatment for metastatic prostate cancer. However, no study to date has evaluated the long-term outcomes of this treatment among patients with prostate cancer after radical prostatectomy ...
Shintaro Maru   +5 more
doaj   +1 more source

Rupture of liver metastasis in high‐volume metastatic prostate cancer patient on androgen deprivation therapy combined with upfront docetaxel chemotherapy

open access: yesIJU Case Reports, 2022
Introduction Recent studies have indicated an improvement in the survival rate of patients using docetaxel in addition to androgen deprivation therapy for high‐volume metastatic hormone‐sensitive prostate cancer.
Kenichi Hata   +3 more
doaj   +1 more source

A Case of Relugolix-Associated Rhabdomyolysis

open access: yesAnnals of Internal Medicine: Clinical Cases, 2023
Androgen deprivation therapy is an integral component of systemic therapy for advanced prostate cancer. However, androgen deprivation therapy causes an array of adverse events secondary to castrate levels of testosterone.
Benjamin Tanenbaum   +3 more
doaj   +1 more source

Prevalence study of intermittent hormonal therapy of Prostate Cancer patients in Spain [version 2; peer review: 2 approved]

open access: yesF1000Research, 2022
Background: Although intermittent androgen deprivation therapy was introduced many years ago to improve patients’ quality of life with the same carcinologic efficiency as continuous hormonal therapy, recent data suggest that intermittency could be ...
Iratxe Urreta   +7 more
doaj   +1 more source

Acquisition of resistance to androgen deprivation therapy in salivary duct carcinoma: A case report

open access: yesRare Tumors, 2018
Salivary duct carcinoma is a relatively rare salivary cancer, and most cases are androgen receptor -positive. Salivary duct carcinoma growth is suggested to be androgen dependent, which can reportedly be controlled by androgen deprivation therapy ...
Koichiro Wasano   +7 more
doaj   +1 more source

Reduced Cardiovascular Capacity and Resting Metabolic Rate in Men with Prostate Cancer Undergoing Androgen Deprivation: A Comprehensive Cross-Sectional Investigation

open access: yesAdvances in Urology, 2015
Objectives. To investigate if androgen deprivation therapy exposure is associated with additional risk factors for cardiovascular disease and metabolic treatment-related toxicities. Methods.
Bradley A. Wall   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy